13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...5, 6, 7, 8, 9, ...17, 18, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-08-10
4:34 pm
Purchase
2023-07-3113GForte Biosciences, Inc.
FBRX
BIOTECHNOLOGY VALUE FUND L P119,284
8.200%
119,284increase
(New Position)
Filing
History
2023-07-06
5:23 pm
Purchase
2023-06-2613GUnicycive Therapeutics, Inc.
UNCY
BIOTECHNOLOGY VALUE FUND L P347,023
9.990%
347,023increase
(New Position)
Filing
History
2023-06-30
4:41 pm
Unchanged
2023-06-2713DMoonLake Immunotherapeutics
MLTX
BIOTECHNOLOGY VALUE FUND L P21,751,284
35.800%
0
(Unchanged)
Filing
History
2023-06-30
4:33 pm
Purchase
2023-06-2213GRevolution Medicines, Inc.
RVMD
BIOTECHNOLOGY VALUE FUND L P7,555,588
7.100%
5,745,039increase
(+317.31%)
Filing
History
2023-06-28
1:51 pm
Sale
2023-06-2613DCTI BioPharma Corp.
CTIC
BIOTECHNOLOGY VALUE FUND L P0
0.000%
-28,463,021decrease
(Position Closed)
Filing
History
2023-06-22
4:47 pm
Purchase
2023-06-1213GDelcath Systems, Inc.
DCTH
BIOTECHNOLOGY VALUE FUND L P1,561,514
9.990%
1,561,514increase
(New Position)
Filing
History
2023-06-05
4:45 pm
Purchase
2023-05-2613GTScan Therapeutics, Inc.
TCRX
BIOTECHNOLOGY VALUE FUND L P4,414,910
9.990%
4,414,910increase
(New Position)
Filing
History
2023-05-30
4:45 pm
Purchase
2023-05-1713GJanux Therapeutics, Inc.
JANX
BIOTECHNOLOGY VALUE FUND L P4,106,945
9.800%
4,106,945increase
(New Position)
Filing
History
2023-05-22
4:47 pm
Purchase
2023-05-1113DPieris Pharmaceuticals, Inc.
PIRS
BIOTECHNOLOGY VALUE FUND L P257,623
22.000%
161,448increase
(+167.87%)
Filing
History
2023-03-24
4:33 pm
Purchase
2023-03-1413GIDEAYA Biosciences, Inc.
IDYA
BIOTECHNOLOGY VALUE FUND L P2,455,089
5.100%
250,000increase
(+11.34%)
Filing
History
2023-03-20
5:04 pm
Purchase
2023-03-1013GProtagonist Therapeutics, Inc.
PTGX
BIOTECHNOLOGY VALUE FUND L P5,025,900
9.600%
3,775,900increase
(+302.07%)
Filing
History
2023-03-16
4:48 pm
Purchase
2023-03-0613GAclaris Therapeutics, Inc.
ACRS
BIOTECHNOLOGY VALUE FUND L P3,360,941
5.000%
84,398increase
(+2.58%)
Filing
History
2023-03-06
5:10 pm
Purchase
2023-02-2413GASLAN Pharmaceuticals Limited
ASLN
BIOTECHNOLOGY VALUE FUND L P1,061,000
9.990%
1,061,000increase
(New Position)
Filing
History
2023-02-14
12:10 pm
Sale
2022-12-3113GMolecular Partners AG
MOLN
BIOTECHNOLOGY VALUE FUND L P4,510,072
12.600%
-16,210decrease
(-0.36%)
Filing
History
2023-02-14
12:05 pm
Purchase
2022-12-3113GIDEAYA Biosciences, Inc.
IDYA
BIOTECHNOLOGY VALUE FUND L P2,205,089
4.600%
240,230increase
(+12.23%)
Filing
History
2023-02-14
12:03 pm
Sale
2022-12-3113GGalmed Pharmaceuticals Ltd.
GLMD
BIOTECHNOLOGY VALUE FUND L P9,665
6.900%
-333decrease
(-3.34%)
Filing
History
2023-02-14
12:03 pm
Sale
2022-12-3113GMerus N.V.
MRUS
BIOTECHNOLOGY VALUE FUND L P2,978,420
6.400%
-1,156,651decrease
(-27.97%)
Filing
History
2023-02-14
12:00 pm
Sale
2022-12-3113G89bio, Inc.
ETNB
BIOTECHNOLOGY VALUE FUND L P3,521,126
6.500%
-376,874decrease
(-9.67%)
Filing
History
2023-02-14
12:00 pm
Purchase
2022-12-3113GPOINT Biopharma Global Inc.
PNT
BIOTECHNOLOGY VALUE FUND L P9,177,748
8.700%
3,587,700increase
(+64.18%)
Filing
History
2023-02-14
11:58 am
Sale
2022-12-3113GCrinetics Pharmaceuticals, Inc.
CRNX
BIOTECHNOLOGY VALUE FUND L P2,736,613
5.100%
-267,266decrease
(-8.90%)
Filing
History
Goto Prev, 0, 1, ...5, 6, 7, 8, 9, ...17, 18, Next